Detalles de la búsqueda
1.
Neutralizing antibody persistence in pediatric travelers from non-JE-endemic countries following vaccination with IXIARO® Japanese encephalitis vaccine: An uncontrolled, open-label phase 3 follow-up study.
Travel Med Infect Dis
; 34: 101616, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32156630
2.
Antibody Persistence up to 3 Years After Primary Immunization With Inactivated Japanese Encephalitis Vaccine IXIARO in Philippine Children and Effect of a Booster Dose.
Pediatr Infect Dis J
; 37(9): e233-e240, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29912844
3.
Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study.
Travel Med Infect Dis
; 22: 18-24, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29549036
4.
Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region.
Pediatr Infect Dis J
; 36(9): 898-904, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28430748
5.
Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers.
Vaccine
; 34(23): 2585-92, 2016 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27079932
Resultados
1 -
5
de 5
1
Próxima >
>>